Genta Incorporated Reports Third Quarter 2011 Financial Results and Recent Corporate Highlights
BERKELEY HEIGHTS, N.J., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA.OB) today reported results for the quarter and nine months ended September 30, 2011. Tesetaxel, the leading oral taxane in clinical development, is the Company's primary research focus. Activities related to tesetaxel in the two priority indications include: